Skip to main content
BioMaxima S.A. logo

BioMaxima S.A. — Investor Relations & Filings

Ticker · BMX ISIN · PLBIOMX00015 LEI · 2594007GAALFMXP4YB89 WAR Manufacturing
Filings indexed 617 across all filing types
Latest filing 2022-04-29 Audit Report / Informat…
Country PL Poland
Listing WAR BMX

About BioMaxima S.A.

https://www.biomaxima.com/

BioMaxima S.A. is a manufacturer specializing in in-vitro diagnostics. The company's primary activities include the development and production of a wide range of products for laboratory diagnostics, with a focus on clinical microbiology. Key product categories include microbiological media, various diagnostic reagents, and specialized laboratory equipment. In addition to its manufacturing operations, BioMaxima also serves as a distributor for products from other global diagnostics firms. The company is actively involved in product innovation, including the development of Minimum Inhibitory Concentration (MIC) tests for antibiotic susceptibility testing.

Recent filings

Filing Released Lang Actions
Jednostkowe Sprawozdanie Finansowe
Audit Report / Information Classification · 98% confidence The document text is titled 'Raport JEDNOSTKOWE SPRAWOZDANIE FINANSOWE za rok 2021' (Individual Financial Statement for the year 2021) and contains a detailed Table of Contents listing sections like 'Jednostkowe sprawozdanie z zysków i strat i innych całkowitych dochodów' (Statement of Profit or Loss and Other Comprehensive Income), 'Jednostkowe sprawozdanie z sytuacji finansowej' (Statement of Financial Position), and 'Jednostkowe sprawozdanie z przepływów pieniężnych' (Statement of Cash Flows). These components are characteristic of a comprehensive annual financial report prepared according to IFRS (Międzynarodowymi Standardami Sprawozdawczości Finansowej). Although the document is in Polish, its structure perfectly matches the definition of a full annual financial report, which corresponds to the '10-K' category in the provided schema, as it is the comprehensive yearly report, not just a release or an audit report. FY 2021
2022-04-29 Polish
Podpis pod listem
Regulatory Filings Classification · 95% confidence The provided document text consists almost entirely of XML structures related to digital signatures (Signature, SignedInfo, KeyInfo, X509Certificate, DigestValue, etc.). This structure is characteristic of digitally signed regulatory filings or documents where integrity and authenticity must be verified, often found within XBRL or other structured data submissions. Crucially, the document does not contain typical narrative content like management discussion, financial statements, or specific announcements (like dividends, board changes, or earnings highlights). It is a technical artifact of a filing process. Given the options, this structure strongly suggests a component of a formal regulatory submission. Since it is not the narrative report itself (like 10-K or ER), and it is a highly specific technical component, the most appropriate general category for a technical, signed regulatory artifact that doesn't fit the specific narrative types is the fallback category, 'Regulatory Filings' (RNS), or potentially 'XLSX' if it were clearly a data file, but the XML signature points more towards a general filing wrapper or validation component. However, looking closely at the references within the signature block, there is a reference to 'BMX_LJ_2021-12-31_pl.xhtml'. This suggests the signature is validating an XHTML document, which is often the format used for the main body of reports like 10-K, IR, or ER. Since the document *is* the signature block and not the report content, and it is a technical component of a filing, 'RNS' (Regulatory Filings - general regulatory announcements/fallback) is the best fit, as it represents the technical wrapper/validation rather than the content itself. If the content were present, we would classify based on that. As it stands, it's a technical filing artifact.
2022-04-29 Polish
List Prezesa Zarządu do akcjonariuszy
Report Publication Announcement Classification · 95% confidence The document is a letter from the CEO of BioMaxima S.A. addressed to shareholders, dated April 29, 2022. It explicitly states 'Przekazujemy Państwu raport roczny BioMaxima S.A. za rok 2021' (We are providing you with the annual report of BioMaxima S.A. for the year 2021). The document itself is a summary letter (under 6,000 characters) announcing the availability of the full annual report and highlighting key financial figures, rather than being the full 10-K/Annual Report document itself. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement. FY 2021
2022-04-29 Polish
Oświadczenie Rady Nadzorczej ws. Komitetu Audytu
Audit Report / Information Classification · 95% confidence The document is dated April 29, 2022, and is titled 'Oświadczenie Rady Nadzorczej BioMaxima S.A. dotyczące funkcjonowania Komitetu Audytu w roku obrotowym 2021' (Statement of the Supervisory Board of BioMaxima S.A. regarding the functioning of the Audit Committee in the 2021 financial year). This document details the composition and functioning of the Audit Committee, which falls under corporate governance practices. While it relates to internal structure, it is more specific than general Governance Information (CGR) as it focuses on a specific board committee's operations and compliance, often required in annual reporting contexts but presented here as a standalone statement. Given the options, 'Governance Information' (CGR) is the most appropriate fit for a statement detailing the structure and compliance of a key board committee (Audit Committee). It is not an Annual Report (10-K), an Audit Report (AR), or a Remuneration Report (DEF 14A). FY 2021
2022-04-29 Polish
Ocena Rady Nadzorczej
Management Reports Classification · 99% confidence The document is titled 'Ocena Rady Nadzorczej BioMaxima S.A. dotycząca sprawozdania z działalności oraz sprawozdania finansowego za rok obrotowy 2021' (Assessment of the Management Board's report on activities and financial statement for the financial year 2021 by the Supervisory Board of BioMaxima S.A.). It explicitly reviews and assesses the Management Board's report on activities, the individual and consolidated financial statements for the year 2021, and the proposal for profit distribution. This document is a formal review/assessment of the annual financial reporting package by the Supervisory Board, which falls under the scope of an Audit Report or Information (AR), as it deals with the review of financial statements and auditor reports, but it is not the full Annual Report (10-K) itself, nor is it a general earnings release (ER). Given the focus on the assessment of the annual financial statements and the auditor's findings, AR is the most appropriate classification.
2022-04-29 Polish
Podpis Biegłego Rewidenta
Regulatory Filings Classification · 95% confidence The provided document text consists entirely of XML digital signature blocks (Signatures, SignedInfo, Reference, DigestValue, X509Data, etc.). This structure is characteristic of a digitally signed document, often used to certify the integrity and authenticity of an official filing, such as an ESEF report or a regulatory submission. Keywords like 'Biomaxima_SA_2021_BSSF_MSSF_SzB_emitent_ESEF_PL.xhtml' within the reference URI strongly suggest this is related to a financial report (likely an Annual or Interim Report formatted for ESEF/XBRL). However, the document *itself* is not the content of the report (like 10-K or IR); it is the cryptographic wrapper proving the report's authenticity. Since the content is purely metadata/signature information and does not contain the actual financial narrative or data, it does not fit the definitions for 10-K, IR, ER, or IP. Given the highly specific nature of the content (a digital signature block) and the lack of a clear document title or narrative, the most appropriate classification is the general fallback category for regulatory artifacts that don't fit specific content types, which is Regulatory Filings (RNS). It is a regulatory artifact confirming the integrity of another document.
2022-04-29 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.